Michael Sember

Michael Sember

Direktör/Styrelseledamot på QUOIN PHARMACEUTICALS, LTD.

Förmögenhet: - $ per 2026-07-31

76 år
Health Technology
Consumer Services
Distribution Services

Profil

Michael T.
Sember
is Vice Chairman at ZelosDx, Inc., Chairman of the Bioindustry Organization of Southern Arizona since 2013, Independent Director at Quoin Pharmaceuticals Ltd. since 2021, and Principal at Accela Advisors since 2007.
Former roles include President & Chief Executive Officer at Soligenix, Inc., Chief Executive Officer at Palyon Medical Corp.
from 2013 to 2015, Chief Executive Officer at Raesedo, Inc. from 2022 to 2023, Chief Executive Officer at Regulonix Holding, Inc. and Regulonix LLC from 2018 to 2020, Chairman at Pylon Electronics, Inc., Director at IOMED, Inc., Senior Director-Global Program Management at Marion Laboratories from 1973 to 1991, Director at Desert Angels, Inc., and Executive Vice President-Business Development at Elan Corp.
Plc from 1991 to 2002.
Education includes an undergraduate degree from the University of Pittsburgh in 1973 and an MBA from Rockhurst University in 1983.

Kända innehav i offentliga företag

FöretagDatumAntal aktierVärderingVärderingsdatum
2026-02-04 0 ( -.--% ) - $ 2026-07-31

Aktiva positioner av Michael Sember

FöretagPositionStart
QUOIN PHARMACEUTICALS, LTD. Direktör/Styrelseledamot 2021-10-28
Direktör/Styrelseledamot -

Tidigare kända positioner av Michael Sember

FöretagPositionSlut
Verkställande Direktör 2020-10-01
Verkställande Direktör 2020-10-01
Verkställande Direktör 2015-01-01
Direktör/Styrelseledamot 2007-08-14
Se detaljerna i Michael Sembers erfarenhet

Michael Sembers utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Relationer

77

Första gradens relationer

13

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Kopplade företag

Privata företag13

Health Technology

Health Technology

Health Technology

Consumer Services

Consumer Services

Distribution Services

Finance

Electronic Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

  1. Börsen
  2. Insiders
  3. Michael Sember